Physician profile
Teri A Devine
NPI 1629213509
$4,105.32
in general payments reported to CMS, 2019-2025
52 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what 89% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $434 · 2022: $785 · 2023: $961 · 2024: $816 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,781 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,780.63 |
| Education | $105.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $541.22 | 2021-2025 | |
| Biogen, INC. | $304.41 | 2021-2024 | Vumerity, Tysabri, Plegridy |
| Teva Pharmaceuticals USA, INC. | $217.76 | 2021-2025 | Austedo Xr, Austedo Xr |
| Lilly USA, LLC | $201.43 | 2021-2025 | Kisunla, Reyvow, Emgality |
| Novartis Pharmaceuticals Corporation | $197.42 | 2022-2025 | |
| Argenx US, INC. | $190.40 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Amneal Pharmaceuticals LLC | $166.16 | 2022-2025 | Rytary, Crexont |
| Lundbeck LLC | $161.77 | 2021-2025 | Vyepti, Rexulti |
| Ucb, INC. | $160.42 | 2023-2025 | Fintepla, Rystiggo |
| Neurocrine Biosciences, INC. | $150.63 | 2023-2025 | Ingrezza, Ongentys |
| Jazz Pharmaceuticals INC. | $120.01 | 2022-2025 | |
| Axsome Therapeutics, INC. | $103.21 | 2022-2025 | Sunosi, Symbravo |
| Sk Life Science, INC. | $99.89 | 2022-2024 | Xcopri |
| Pfizer INC. | $97.46 | 2024-2025 | |
| Eisai INC. | $86.24 | 2021-2024 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teri Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.